TECHWIRE 30
(CIX: WRAL30)  921.78  up arrow+3.67  (0.4 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: Apple)  433.26  down arrow-1.32  (-0.3 %)  Updated: 08:10 PM EDT, May 17 2013
(NY: Quintiles)  45.52  down arrow-0.33  (-0.72 %)  Updated: 06:40 PM EDT, May 17 2013
(OP: BASF SE)  95.81  up arrow+1.12  (1.18 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: BioCryst)  1.71  down arrow-0.02  (-1.16 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: BioDelivery)  4.74  down arrow-0.16  (-3.27 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: CEMP)  6.70  down arrow-0.01  (-0.15 %)  Updated: 04:00 PM EDT, May 17 2013
(NQ: Cisco Systems)  24.24  up arrow+0.35  (1.48 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: Cornerstone)  9.00  up arrow+0.09  (1.01 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: Cree)  60.31  up arrow+0.44  (0.73 %)  Updated: 04:00 PM EDT, May 17 2013
(NQ: DARA)  0.70  down arrow-0.04  (-5.06 %)  Updated: 08:10 PM EDT, May 17 2013
(NY: EMC Corp.)  24.24  up arrow+0.18  (0.75 %)  Updated: 06:40 PM EDT, May 17 2013
(NQ: Extreme Networks)  3.46  up arrow+0.04  (1.17 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: Facebook)  26.25  up arrow+0.12  (0.46 %)  Updated: 04:00 PM EDT, May 17 2013
(NY: GlaxoSmithKline)  52.22  up arrow+0.11  (0.21 %)  Updated: 06:40 PM EDT, May 17 2013
(NQ: Google)  909.18  up arrow+5.31  (0.59 %)  Updated: 04:00 PM EDT, May 17 2013
(NY: IBM)  208.44  up arrow+3.75  (1.83 %)  Updated: 06:40 PM EDT, May 17 2013
(NY: LH)  98.97  up arrow+1.29  (1.32 %)  Updated: 06:40 PM EDT, May 17 2013
(OP: Lenovo Group)  18.00  up arrow+0.1  (0.56 %)  Updated: 08:10 PM EDT, May 17 2013
(NY: MRK)  45.99  down arrow-0.38  (-0.82 %)  Updated: 06:40 PM EDT, May 17 2013
(NQ: Microsoft Corp)  34.87  up arrow+0.79  (2.32 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: NetApp)  37.84  down arrow-0.62  (-1.61 %)  Updated: 08:10 PM EDT, May 17 2013
(NY: Novartis AG ADS)  74.15  down arrow-0.86  (-1.15 %)  Updated: 06:40 PM EDT, May 17 2013
(OP: Novozymes A/S)  34.26  down arrow-0.29  (-0.84 %)  Updated: 08:10 PM EDT, May 17 2013
(NY: Pfizer)  28.96  down arrow-0.29  (-0.99 %)  Updated: 06:40 PM EDT, May 17 2013
(NQ: Pozen)  4.90  up arrow+0.04  (0.82 %)  Updated: 08:10 PM EDT, May 17 2013
(NY: Red Hat)  54.99  up arrow+0.28  (0.51 %)  Updated: 06:40 PM EDT, May 17 2013
(NQ: BBRY)  14.62  down arrow-0.07  (-0.48 %)  Updated: 08:10 PM EDT, May 17 2013
(NQ: Salix)  59.28  up arrow+0.09  (0.15 %)  Updated: 04:00 PM EDT, May 17 2013
(NQ: SQI)  24.50  down arrow-0.45  (-1.8 %)  Updated: 08:10 PM EDT, May 17 2013

Posts tagged “Quintiles”

August 5, 2002

Premium Lock Week in Review: Region's Roller Coaster Ride Continues

We're up, we're down, we're holding on for dear life - last week saw a mix of highs and lows for the Carolinas and Georgia.

July 25, 2002

Premium Lock Burned by the Market: BellSouth Leads Way But Has Plenty of Company

A 'Top 10' list of losers from Georgia shows $42.45B loss in market capitalization. North Carolina's 'Top 10' sheds $14B of $27.3 in value.

July 21, 2002

Premium Lock Week in Review: A New CEO is the Must-Have Accessory for Q3

Changes in the executive suite dominate the news. Sales and acquisitions make headlines, too. An interesting investment deal highlights a slow week of venture moves.

July 15, 2002

Premium Lock Herd on the Street: Biotech Is 'Flavor of the Month' For the VCs

Burned by IT flameouts in recent years, some major regional VC players are shifting their focus to funding biotechnology startups. At least two other funds are starting with a biotech-only premise.

July 7, 2002

Premium Lock Venture Profile: Thompson Clive Venture Capital Has an Eye on Triangle

Firm, which opened Raleigh office in 2001, insists on being selective, looks for second-round and later deals up to $3 million in size.

June 18, 2002

Premium Lock Aurora Puts Part of New Fund in Pittsburgh Bioinformatics Firm

Durham VCs join $12.5 million round for TissueInformatics. Aurora sees startup's technology as huge advance for tissue analysis.

June 4, 2002

Premium Lock Raleigh Clinical Trials Firm Lands $11 Million in New Funding

INC Research, which focuses on oncology and central nervous system drugs, looks to expand into Europe and build its data management division. Crosspoint Venture leads round.

May 20, 2002

Premium Lock North Carolina Can Help Lead War Against Bio-Terror, Burr Says

Rep. Richard Burr (R-NC) to tell Biotech 2002 audience that NC is in a "tremendous position" to profit from and to lead the national effort to shore up its defenses.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Jim Roberts
Entrepreneurship
Scroll

Videos

 
  • Allscripts bringing hundreds of jobs…

  • Nonprofit to handle NC economic…

  • Raleigh goes green, saves green with…

  • Gov. Pat McCrory speaks to NC Chamber

  • NC business leaders unveil job growth…

  • Investment expert: Leading is key in…

  • Retailers tout deals on Twitter

  • Vision for RTP: Social centerpiece